These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21740997)

  • 21. Tomotherapy for prostate adenocarcinoma: a report on acute toxicity.
    Keiler L; Dobbins D; Kulasekere R; Einstein D
    Radiother Oncol; 2007 Aug; 84(2):171-6. PubMed ID: 17692975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to "Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy" (Int J Radiat Oncol Biol Phys 2009, in press).
    Froehner M; Koch R; Litz RJ; Wirth MP
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1274. PubMed ID: 20206022
    [No Abstract]   [Full Text] [Related]  

  • 23. Dose escalation using a hypofractionated, intensity-modulated radiation therapy boost for localized prostate cancer: preliminary results addressing concerns of high or low alpha/beta ratio.
    Shridhar R; Bolton S; Joiner MC; Forman JD
    Clin Genitourin Cancer; 2009 Oct; 7(3):E52-7. PubMed ID: 19815482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calculated risk of fatal secondary malignancies from intensity-modulated radiotherapy: In regard to Kry et al. (Int J Radiat Oncol Biol Phys 2005;62:1195-1203).
    Schneider U
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1290; author reply 1290-1. PubMed ID: 16504771
    [No Abstract]   [Full Text] [Related]  

  • 25. Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?
    Chen MJ; Weltman E; Hanriot RM; Luz FP; Cecílio PJ; da Cruz JC; Moreira FR; Santos AS; Martins LC; Nadalin W
    Radiat Oncol; 2007 Jan; 2():6. PubMed ID: 17224072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.
    Zelefsky MJ; Chan H; Hunt M; Yamada Y; Shippy AM; Amols H
    J Urol; 2006 Oct; 176(4 Pt 1):1415-9. PubMed ID: 16952647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer.
    Cheng JC; Schultheiss TE; Nguyen KH; Wong JY
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):351-7. PubMed ID: 18164841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy: In regard to Lee et al. (Int J Radiat Oncol Biol Phys 2006;64:301-320).
    Dai J; Hu Y
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1594-5. PubMed ID: 16863939
    [No Abstract]   [Full Text] [Related]  

  • 29. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer: in regard to Schoenfeld et al. (Int J Radiat Oncol Biol Phys 2008;71:377-385).
    Studer GM; Glanzmann C
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1271-2; author reply 1272. PubMed ID: 18954722
    [No Abstract]   [Full Text] [Related]  

  • 30. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer.
    Nath SK; Sandhu AP; Rose BS; Simpson DR; Nobiensky PD; Wang JZ; Millard F; Kane CJ; Parsons JK; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):435-41. PubMed ID: 19939580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to "Intraoperative radiotherapy during radical prostatectomy for locally advanced prostate cancer: technical and dosimetric aspects" (Int J Radiat Oncol Biol Phys 2009; in press).
    Thoms J; Bristow R; Warde P; Supiot S
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1277; author reply 1277. PubMed ID: 20206029
    [No Abstract]   [Full Text] [Related]  

  • 32. Response to "The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients." (Int J Radiat Oncol Biol Phys 2010;76:342-348).
    Froehner M; Wirth MP
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1279; author reply 1280. PubMed ID: 20542389
    [No Abstract]   [Full Text] [Related]  

  • 33. Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer.
    Alicikus ZA; Yamada Y; Zhang Z; Pei X; Hunt M; Kollmeier M; Cox B; Zelefsky MJ
    Cancer; 2011 Apr; 117(7):1429-37. PubMed ID: 21425143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer (Int J Radiat Oncol Biol Phys 2010;76:342-348).
    Hyde C
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1607; author reply 1607. PubMed ID: 20637987
    [No Abstract]   [Full Text] [Related]  

  • 35. In regard to Fiorino et al.: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:953-962).
    Bauman G; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):912-4; author reply 914-5. PubMed ID: 15183497
    [No Abstract]   [Full Text] [Related]  

  • 36. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T; Lüdemann L; Taupitz M; Böhmer D; Beyersdorff D
    Radiother Oncol; 2009 Nov; 93(2):241-5. PubMed ID: 19748143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer.
    Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin J; Lizarde J; Macedo J; Ravera J; Tokita KM
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):824-30. PubMed ID: 20510195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of high- and low-source strength (125)I prostate seed implants: In regard to Narayana et al. (Int J Radiat Oncol Biol Phys 2005;61:44-51).
    Moerland MA; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):941-2. PubMed ID: 15936582
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
    Al-Mamgani A; Heemsbergen WD; Peeters ST; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):685-91. PubMed ID: 18718725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer.
    Fiorino C; Alongi F; Perna L; Broggi S; Cattaneo GM; Cozzarini C; Di Muzio N; Fazio F; Calandrino R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):29-35. PubMed ID: 19467803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.